Allos Therapeutics, Inc.
(NASDAQ:ALTH)|
5.96 -0.80 (-11.83%) Nov 19 - Close |
|
|
|
After-Hours 6.93 +0.97 (16.28%) Wed, 19 Nov 2008 6:50 PM
- Compare ALTH with:
- View: Line | Candlestick
Company Profile
Allos Therapeutics, Inc.
11080 Circlepoint Road
Westminister, CO 80020
United States - Map
Phone: (303) 426-6262
Fax: (303) 412-9160
Website: www.allos.com
State of incorporation: Delaware
CEO: Paul L. Berns
Employees: 66
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
dev,and commercialize small molecule drugs
A biopharmaceutical company which is engaged in developing and commercializing innovative small molecule drugs for the treatment of cancer.
Recent news for ALTH
-
Bright Spots for Investors Discussed in Wall Street Transcript Biotechnology Report
Wall Street Transcript - 20 hours ago
-
ALLOS THERAPEUTICS INC Financials
EDGAR Online Financials - Nov 11 at 9:04 ET
-
EDGAR Online - Nov 10 at 5:09 ET
-
EDGAR Online - Nov 10 at 9:20 ET
-
Business Wire - Nov 10 at 9:17 ET
-
Health Winners & Losers: Amgen
TheStreet.com - Nov 06 at 3:46 ET
-
New Star Analyst Rankings for ALLOS THERAPEUTICS
StarMine - Nov 06 at 9:25 ET
-
Allos Therapeutics Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 06 at 12:28 ET
-
Allos Therapeutics, Inc. Earnings Call scheduled for 4:15 pm ET today
CCBN - Nov 05 at 4:15 ET
-
EDGAR Online - Nov 05 at 4:05 ET
